Life Technologies, RainTree Oncology To Deliver Molecular Tumor Testing to Community Oncologists
The companies will educate private payors and health plans about the benefits of next-generation sequencing.
Read MorePosted by Judy O'Rourke | Aug 5, 2013 | Cancer, Molecular Diagnostics |
The companies will educate private payors and health plans about the benefits of next-generation sequencing.
Read MorePosted by Judy O'Rourke | Jul 26, 2013 | Cardiovascular, Diabetes & Metabolic Diseases, Molecular Diagnostics |
Warfarin, Plavix sensitivity tests, and thrombophilia risk test provide personalized risk assessment, diagnosis, and treatment.
Read MorePosted by Judy O'Rourke | Jul 23, 2013 | Respiratory Disease |
Test identifies diagnostic biomarkers.
Read MorePosted by Judy O'Rourke | Jul 23, 2013 | Molecular Diagnostics |
The company’s clinical services lab uses next-generation DNA and genetic analysis technologies that include multiplex real-time PCR, whole genome mapping, and next-generation sequencing.
Read MorePosted by Judy O'Rourke | Jul 22, 2013 | Miscellaneous |
Directories are provided free of charge to participating labs and clinics.
Read More